Original Research
Published on 17 Apr 2025
Efgartigimod as a fast-acting treatment in generalized very-late-onset myasthenia gravis
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2025.1579859
- 4,790 views
- 7 citations


